Colistin heteroresistance in Citrobacter freundii clinical isolates from Republic of Korea

Jong Hyun Shin,Dongwoo Shin,Ki Tae Kwon,Kwan Soo Ko
DOI: https://doi.org/10.1016/j.diagmicrobio.2024.116187
IF: 2.983
2024-01-18
Diagnostic Microbiology and Infectious Disease
Abstract:We investigated colistin heteroresistance in Citrobacter freundii isolates from Korean hospitals. Using population analysis profiling (PAP), we detected colistin heteroresistance in 31.3% of isolates. Among these, ST217 was the most prevalent clone (58.5%), particularly within colistin-heteroresistant isolates (80.0%). Interestingly, the second most common clone, ST248, was not found in heteroresistant isolates. We identified amino acid changes in PhoQ, PmrA, and PmrB, along with mRNA overexpression in pmrB and arnD . Colistin monotherapy showed no efficacy, but a combination of colistin and ciprofloxacin successfully eradicated all five isolates, even at 0.5 × minimum inhibitory concentrations. This study underscores the high prevalence of colistin heteroresistance in C. freundii isolates, limiting the effectiveness of colistin monotherapy. Combining colistin with ciprofloxacin may offer a viable treatment option for C. freundii infections.
infectious diseases,microbiology
What problem does this paper attempt to address?